about
Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys.Molecular switches of the κ opioid receptor triggered by 6'-GNTI and 5'-GNTI.Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedationCollybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activityWill peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?κ Agonists as a novel therapy for menopausal hot flashes.Purification and mass spectrometric analysis of the kappa opioid receptor.Peptide kappa opioid receptor ligands: potential for drug development.Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.The role of kappa-opioid receptor activation in mediating antinociception and addiction.Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.EMERGING THERAPIES AND NOVEL APPROACHES TO VISCERAL PAIN.(-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice.κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic painRegulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.Drug management of visceral pain: concepts from basic research.Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.Effects of peripheral κ opioid receptor activation on inflammatory mechanical hyperalgesia in male and female ratsDiagnosis and treatment of noncardiac chest pain.Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout micePeripheral mechanisms of pain and analgesia.The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.Kappa Opioid Receptor Agonist and Brain Ischemia.Opioid Medications in the Management of Chronic Abdominal Pain.In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug designRelative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.Comparison of oxycodone and sufentanil for patient-controlled intravenous analgesia after laparoscopic radical gastrectomy: A randomized double-blind clinical trial.Development of a Peptide-derived orally-active kappa-opioid receptor agonist targeting peripheral pain.Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors.Activation of TREK-1 by morphine results in analgesia without adverse side effects.A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.Comparison of nalbuphine and sufentanil for colonoscopy: A randomized controlled trial.G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.Prevalence of dysphoria after fentanyl in dogs undergoing stifle surgery.
P2860
Q24676597-F48C2A0E-C92E-45F9-B2B8-BCA9D38E7C14Q27302413-BD404C42-EF3A-4274-B388-89BEFBC85C90Q28259561-A4B24A21-2FFA-457F-A029-6CEB6AEF2AD3Q28275440-DBE5090D-9B76-4ADC-AC7B-C4B507634186Q30250027-68F220DC-3880-4E95-B3A4-550127B4AD73Q30355071-30CD4269-BA30-4AC8-9394-8CE9B40A7CFDQ33355290-A7EA8ED0-9F40-4119-B05E-B9607C0E8E97Q33442900-C8CDA13F-F080-4A6F-9F6B-0087F0AE9885Q34026235-23EC33C4-A39D-4216-9620-E479EDCB83F0Q34132638-E881E822-556C-4365-9EC4-33ED41BADFB4Q34274321-B90E2282-A3CC-4914-8D4B-813AFBB8B08CQ34485671-1DB04951-FA2D-4642-8AE7-8D506D9643E1Q34957270-7E4C1A38-E02F-4314-A3A1-5FD338884E02Q35039212-EB06131F-B622-4AF0-A043-AC37F44B72E4Q35077913-3E8AB80A-9AB1-48A9-8EFF-5B0E017D47F8Q35752958-95E518EA-B521-4C03-94AF-22276542CC14Q35947915-0C872768-E147-45CF-85DB-12E5147AFDE7Q36163631-A90C06DD-3BF1-41B8-9F56-7CE9916BD3B0Q36186182-B6A22A2F-84D0-4556-910A-E9D9DA3113F3Q36188108-FF02B56B-FAE1-4DEC-BC38-3D6B2E261B2FQ36285951-5EF374F9-EC1B-41A4-8767-B06B79C58D84Q37162582-F370FFDE-9B43-405D-85B9-CEE1330A9FEAQ37314270-FFE7E3CC-3807-4429-B5A6-48255386BF83Q37427854-66C57019-945F-4B27-9EA9-850DD9356C9FQ37444418-9B4489D4-6E2D-46EE-85E4-E3451FB37F64Q38312641-73859587-6660-4ECB-95C7-F5B11A98BB1DQ39151652-B3A5BF5D-F03B-4B5F-BF59-F1A6C3DAB317Q39209988-6EC4518A-2C31-44B1-B5C8-D0EE87449531Q39412016-9995266D-91E2-42A6-A0D3-E033A176D5E2Q39522869-ACFEDBEF-B5CE-4F4D-8B7E-EB14F635D630Q39652067-D8E73EB4-C1F1-41BF-867F-55F894D0ABC4Q39887680-3693D774-9A2A-45B9-B2E2-B81106EE1D0AQ41447652-AA0B0707-67FB-44C3-9F54-3B1F0834B5DAQ41763792-0231FB06-C694-4B72-ADF2-7D0BD7890A83Q41900915-70808871-0E4C-4FAE-936F-9873275F3608Q44003399-B4E23967-5972-49C6-8DF8-1795E5CEE99EQ44336990-1AE9EB9E-2CF4-4E65-8B07-6EA18F59CEDFQ47094508-D3DED01C-202A-45F7-BD4F-0203C821D16CQ47104016-31B5A552-ADB3-4ABD-A75E-AAC6E8100175Q48107989-E32615DC-693C-40B5-BC99-A1D721DA9D82
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Peripheral kappa-opioid agonists for visceral pain.
@ast
Peripheral kappa-opioid agonists for visceral pain.
@en
type
label
Peripheral kappa-opioid agonists for visceral pain.
@ast
Peripheral kappa-opioid agonists for visceral pain.
@en
prefLabel
Peripheral kappa-opioid agonists for visceral pain.
@ast
Peripheral kappa-opioid agonists for visceral pain.
@en
P2860
P356
P1476
Peripheral kappa-opioid agonists for visceral pain.
@en
P2093
Pierre J-M Rivière
P2860
P304
P356
10.1038/SJ.BJP.0705763
P407
P577
2004-03-29T00:00:00Z